Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 21.1713.2110.299.214.22

What is the latest EV/Core EBITDA ratio of SAKAR HEALTHCARE ?

The latest EV/Core EBITDA ratio of SAKAR HEALTHCARE is 21.17 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202421.17
Mar202313.21
Mar202210.29
Mar20219.21
Mar20204.22

How is EV/Core EBITDA of SAKAR HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2024 21.17
60.26
Mar2023 13.21
28.38
Mar2022 10.29
11.73
Mar2021 9.21
118.25
Mar2020 4.22 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare EV/Core EBITDA ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹695.0 Cr 1.2% 2.7% 2.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,824.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,355.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹122,929.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,502.0 Cr 2% -0.8% 15.7% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

1.2%

2.7%

2.2%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses